These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29393580)

  • 1. Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis.
    Chen X; Zhai Z; Huang K; Xie W; Wan J; Wang C
    Clin Respir J; 2018 Jun; 12(6):2065-2074. PubMed ID: 29393580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis.
    Becattini C; Manina G; Busti C; Gennarini S; Agnelli G
    Thromb Res; 2010 Jul; 126(1):e51-6. PubMed ID: 20172593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
    Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
    J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study).
    Ulrich S; Speich R; Domenighetti G; Geiser T; Aubert JD; Rochat T; Huber L; Treder U; Fischler M
    Swiss Med Wkly; 2007 Oct; 137(41-42):573-80. PubMed ID: 17990150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term advanced therapy with bosentan improves symptoms and prevents deterioration of inoperable chronic thromboembolic pulmonary hypertension.
    Nishikawa-Takahashi M; Ueno S; Kario K
    Life Sci; 2014 Nov; 118(2):410-3. PubMed ID: 24690389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension: an endothelin receptor antagonist improves the peak PETCO2.
    Hirashiki A; Adachi S; Nakano Y; Kono Y; Shimazu S; Shimizu S; Morimoto R; Okumura T; Takeshita K; Yamada S; Murohara T; Kondo T
    Life Sci; 2014 Nov; 118(2):397-403. PubMed ID: 24641953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.
    Surie S; Reesink HJ; Marcus JT; van der Plas MN; Kloek JJ; Vonk-Noordegraaf A; Bresser P
    Clin Cardiol; 2013 Nov; 36(11):698-703. PubMed ID: 24037998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bosentan for chronic thromboembolic pulmonary hypertension.
    Confalonieri M; Kodric M; Longo C; Vassallo FG
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?
    van Thor MCJ; Ten Klooster L; Snijder RJ; Kelder JC; Mager JJ; Post MC
    Lung; 2019 Dec; 197(6):753-760. PubMed ID: 31583452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of randomized controlled trials of bosentan for treatment of pulmonary arterial hypertension.
    Lee YH; Song GG
    Korean J Intern Med; 2013 Nov; 28(6):701-7. PubMed ID: 24307846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of bosentan in patients with chronic venous thromboembolic pulmonary hypertension].
    Segovia Cubero J; Ortiz Uribe JC; Gómez Bueno M; Moñivas Palomero V; González González M; Alonso-Pulpón Rivera L
    Med Clin (Barc); 2007 Jan; 128(1):12-4. PubMed ID: 17266886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bosentan for patients with chronic thromboembolic pulmonary hypertension.
    Vassallo FG; Kodric M; Scarduelli C; Harari S; Potena A; Scarda A; Piattella M; Cassandro R; Confalonieri M
    Eur J Intern Med; 2009 Jan; 20(1):24-9. PubMed ID: 19237088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis.
    Chen Y; Li F; Luo J; Chen J; Luo P; Li J
    Can Respir J; 2021; 2021():1626971. PubMed ID: 34512819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
    Channick RN; Simonneau G; Sitbon O; Robbins IM; Frost A; Tapson VF; Badesch DB; Roux S; Rainisio M; Bodin F; Rubin LJ
    Lancet; 2001 Oct; 358(9288):1119-23. PubMed ID: 11597664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
    Cannon JE; Pepke-Zaba J
    Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.
    Charalampopoulos A; Gibbs JS; Davies RJ; Gin-Sing W; Murphy K; Sheares KK; Pepke-Zaba J; Jenkins DP; Howard LS
    J Appl Physiol (1985); 2016 Sep; 121(3):623-8. PubMed ID: 27418685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.
    Fine N; Dias B; Shoemaker G; Mehta S
    Can J Cardiol; 2009 Mar; 25(3):e63-8. PubMed ID: 19279988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.
    McLaughlin VV; Oudiz RJ; Frost A; Tapson VF; Murali S; Channick RN; Badesch DB; Barst RJ; Hsu HH; Rubin LJ
    Am J Respir Crit Care Med; 2006 Dec; 174(11):1257-63. PubMed ID: 16946127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension.
    Hoeper MM
    Eur Respir Rev; 2015 Jun; 24(136):272-82. PubMed ID: 26028639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease.
    Ibrahim R; Granton JT; Mehta S
    Can Respir J; 2006; 13(8):415-20. PubMed ID: 17149459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.